Royalty Pharma (RPRX)Wedge Capital Management L L P reduced its stake -120K shares

770K

Shares reported · -120K vs prior quarter

0.71%

Disclosed portfolio weight

$43.2M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 14, 2026Insider · 2 peopleInsiders: 2 sales (~$888K)
2. May 20, 2026InsiderOfficer sold ~$722K of RPRX shares in the open market
3. May 22, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
4. May 26, 2026InsiderCFO sold ~$3.48M of RPRX shares in the open market
5. Jun 23, 2026Insider · 1 personInsiders: 2 sales (~$8.2M)
6. Jun 24, 2026InsiderOfficer sold ~$502K of RPRX shares in the open market
7. Jun 30, 2026Insider · 1 personInsiders: 4 sales (~$7.3M)
8. Jul 1, 2026InsiderOfficer sold ~$508K of RPRX shares in the open market

What came next

1. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 13, 2026Insider · 1 personInsiders: 2 sales (~$646K)
3. Aug 18, 2026InsiderChair sold ~$6M of RPRX shares in the open market
4. Sep 22, 2026Insider · 1 personInsiders: 2 sales (~$5.9M)
5. Sep 28, 2026InsiderOfficer sold ~$239K of RPRX shares in the open market
6. Oct 5, 2026InsiderOfficer sold ~$236K of RPRX shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Royalty Pharma

For Royalty Pharma, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RPRX page.

How this filing works

• SEC Form 13F

Other disclosures at Royalty Pharma

• SEC Form 4Oct 6, 2026
• SEC Form 144Oct 5, 2026
• SEC Form 4Oct 1, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 4Aug 20, 2026

Everything OQRO holds on this company is on its RPRX page.